atorvastatin has been researched along with Endomyocardial Fibrosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, T; Guo, B; Wang, L; Xue, L | 1 |
| Chen, J; Gao, L; Gao, X; He, X; Qi, Z; Zhang, K; Zhou, Y | 1 |
2 other study(ies) available for atorvastatin and Endomyocardial Fibrosis
| Article | Year |
|---|---|
Atorvastatin Prevents Myocardial Fibrosis in Spontaneous Hypertension via Interleukin-6 (IL-6)/Signal Transducer and Activator of Transcription 3 (STAT3)/Endothelin-1 (ET-1) Pathway.
Topics: Animals; Atorvastatin; Blood Pressure; Cardiomyopathies; Disease Models, Animal; Endomyocardial Fibrosis; Endothelin-1; Fibrosis; Hypertension; Interleukin-6; Male; Myocardium; Phosphorylation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT3 Transcription Factor | 2019 |
Atorvastatin Ameliorates Radiation-Induced Cardiac Fibrosis in Rats.
Topics: Animals; Atorvastatin; Cardiotoxicity; Dose-Response Relationship, Drug; Endomyocardial Fibrosis; Immunologic Factors; Male; Radiation Dosage; Radiation-Protective Agents; Radiation, Ionizing; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2015 |